What is the total value of India's pharmaceutical export to Austria?

India exported pharmaceuticals worth $14.9M to Austria across 313 verified shipments.

Which companies in Austria import pharmaceuticals from India?

1. FRESENIUS KABI INDIA PRIVATE LIMITED — $13.9M. 2. TAKEDA BIOPHARMACEUTICALS INDIA PRIVATE LIMITED — $3.2M. 3. NOVARTIS INDIA LIMITED — $559.5K. 40 buyers total.

What pharmaceutical products does India export most to Austria?

1. Amino ($9.9M, 66.5%); 2. Omega ($4.0M, 26.8%); 3. Sodium ($280.3K, 1.9%); 4. Mycophenolate ($279.7K, 1.9%); 5. Serum ($255.5K, 1.7%)

Why does Austria import pharmaceuticals from India?

India's cost-competitive generic drug manufacturing, WHO-GMP certified facilities, and broad product portfolio. This $14.9M corridor reflects quality compliance and pricing advantages.

What certifications do Indian pharmaceutical exporters need to supply Austria?

WHO-GMP certification, EU GMP approval (for EU markets), product dossier registration (CTD format), and ICH guideline compliance.

What is the average shipment value for India to Austria pharmaceutical trade?

$47.7K per consignment across 313 shipments.

How many Indian pharmaceutical companies export to Austria?

42 Indian companies. Largest: FRESENIUS KABI (SINGAPORE) PTE LTD. with $11.8M.

How can I find verified Indian pharmaceutical suppliers for Austria?

TransData Nexus covers 42 active exporters with shipment history and trade values at transdatanexus.com.

Austria to India Pharmaceutical Import (2026) — $14.9M, 42 Foreign Suppliers | TransData Nexus

Q: Who are the top Indian pharmaceutical exporters to Austria?

1. FRESENIUS KABI (SINGAPORE) PTE LTD. — $11.8M. 2. Takeda Pharmaceuticals International AG — $3.5M. 3. FRESENIUS KABI ASIA PACIFIC LTD — $1.3M. Total: 42 suppliers.

Austria to India Pharmaceutical Import (2026) — $14.9M, 42 Foreign Suppliers | TransData Nexus | TransData Nexus

Top Pharmaceutical Formulations — Austria to India

#	Formulation	Value	Share
1	Amino	$9.9M	66.5%
2	Omega	$4.0M	26.8%
3	Sodium	$280.3K	1.9%
4	Mycophenolate	$279.7K	1.9%
5	Serum	$255.5K	1.7%
6	Amphotericin	$55.8K	0.4%
7	Lisinopril	$19.7K	0.1%
8	Probiotics	$17.3K	0.1%
9	Cefixime	$16.7K	0.1%
10	Rosuvastatin	$9.1K	0.1%
11	Atorvastatin	$7.6K	0.1%
12	Empagliflozin	$6.4K	0.0%
13	Metformin	$6.4K	0.0%
14	Ezetimibe	$6.0K	0.0%
15	Zinc	$5.7K	0.0%

India imports 20+ pharmaceutical formulations from Austria with a combined trade value of $14.9M. Key products include Amino ($9.9M), Omega ($4.0M), Sodium ($280K), Mycophenolate ($280K), Serum ($256K). These are finished dosage forms — tablets, capsules, injectables, and combination drugs — shipped from Indian manufacturing facilities with FDA, WHO-GMP, and EU GMP certifications. Data from 313 verified Indian Customs (DGFT) shipment records.

Top Pharmaceutical Products — Austria to India Trade Routes

1Amino$9.9M

2Omega$4.0M

3Sodium$280K

4Mycophenolate$280K

5Serum$256K

6Amphotericin

Top Austria Suppliers to India

1Fresenius Kabi (singapore) Pte Ltd.

$11.8M

2Takeda Pharmaceuticals International Ag

$3.5M

3Fresenius Kabi Asia Pacific Ltd

$1.3M

4Fresenius Kabi Singapore Pte Ltd

$585K

5Novartis Pharma Ag

$559K

Trade Statistics

Total Value$14.9M

Shipments313

Indian Exporters42

Austria Buyers40

Avg Shipment$48K

Products39

Other Import Origins

United States$2.7B Germany$929.2M China$767.5M Italy

Last updated: March 28, 2026

India–Austria Pharmaceutical Trade Corridor Analysis

Historical evolution, India's market position, and recent developments

1Trade Corridor Evolution

The pharmaceutical trade corridor between Austria and India has experienced significant growth over the past decade. In 2024, Austria exported pharmaceutical products valued at $35.45 million to India, marking a substantial increase from previous years. This growth is attributed to Austria's strong pharmaceutical manufacturing capabilities and India's expanding healthcare needs. The trade relationship has been further bolstered by India's commitment to enhancing its healthcare infrastructure and Austria's focus on exporting high-quality pharmaceutical products.

2Austria's Role in India's Pharma Imports

Austria plays a pivotal role in India's pharmaceutical imports, contributing significantly to the diversity and quality of medicines available in the Indian market. In 2024, pharmaceutical products accounted for $35.45 million of Austria's total exports to India, underscoring the importance of this sector in bilateral trade. India imports a range of pharmaceutical products from Austria, including human and animal blood products, vaccines, and medicaments, reflecting Austria's comprehensive pharmaceutical export portfolio.

3Recent Developments

Austria Regulatory Landscape for Indian Pharmaceutical Exports

Registration process, GMP requirements, import documentation

1CDSCO Registration Process

Austrian pharmaceutical companies seeking to import products into India must navigate the CDSCO registration process. This involves obtaining an Import License (Form 10) and a Registration Certificate (Form 41) for each product. The process includes submitting an application with detailed product information, manufacturing site details, and compliance with Good Manufacturing Practices (GMP). Clinical trial data may be required, depending on the product's nature. The timeline for approval varies but typically ranges from several months to a year, depending on the product's complexity and the completeness of the application.

2GMP & Manufacturing Standards

India requires that foreign manufacturing sites adhere to GMP standards recognized by the World Health Organization (WHO). Austrian manufacturers must ensure their facilities comply with these standards to meet CDSCO requirements. The CDSCO conducts inspections to verify compliance, and products from WHO-prequalified facilities are often given priority in the approval process. Maintaining high manufacturing standards is crucial for Austrian companies to establish and sustain a presence in the Indian market.

3Import Documentation

To import pharmaceutical products into India, Austrian companies must provide several key documents:

Import License (Form 10): Authorizes the importation of specific pharmaceutical products.

Registration Certificate (Form 41): Confirms that the product is registered with the CDSCO.

No Objection Certificate (NOC): Issued by the Ministry of Health and Family Welfare, indicating no objection to the import.

Test License: Required for products intended for testing or clinical trials.

Customs Documentation: Includes commercial invoices, packing lists, and certificates of analysis.

Adhering to these documentation requirements is essential for smooth customs clearance and market entry.

TransData Nexus Research · Austria regulatory databasesMar 2026

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Data Source: Indian Customs (DGFT) export shipping bill records covering all pharmaceutical shipments from India.
2.Country Matching: Shipments to Austria identified using destination country codes from customs declarations.
3.Statistical Normalization: Values are statistically normalized to remove outlier transactions and ensure accurate market share representation.
4.Coverage: 313 verified shipments from 42 Indian exporters to 40 Austria buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

42 Exporters

40 buyers tracked

Expert-Reviewed

By pharmaceutical trade specialists

Austria to India Pharmaceutical Import

Top Pharmaceutical Formulations — Austria to India

Top Pharmaceutical Products — Austria to India Trade Routes

Top Austria Suppliers to India

Trade Statistics

Other Import Origins

India–Austria Pharmaceutical Trade Corridor Analysis

1Trade Corridor Evolution

2Austria's Role in India's Pharma Imports

3Recent Developments

Top Indian Buyers from Austria

Product Routes

Full Dataset Access

Austria Regulatory Landscape for Indian Pharmaceutical Exports

1CDSCO Registration Process

2GMP & Manufacturing Standards

3Import Documentation

Product Categories & Therapeutic Trends — India to Austria

1Dominant Import Categories

2Innovation & Specialty Imports

3Import Demand Drivers

Trade Policy & Tariff Intelligence — India and Austria

1India's Import Tariff Structure

2Trade Agreements & Preferences

3IP, Patents & Price Control

Supply Chain & Logistics — India to Austria Pharma Shipments

1Shipping Routes & Transit

2Port Infrastructure

3Indian Customs & Cold Chain

Market Opportunity Assessment — Austria for Indian Pharma

1India's Import Dependency

2Austria Companies in India

3Outlook & Self-Reliance

FAQ — India to Austria Pharmaceutical Trade